Orthobiologics Industry Projected to Garner Significant Revenues by 2018 – 2025: Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corpor

The Orthobiologics Industry is expected to be around $10 billion by 2025. The market is primarily driven by factors such as increasing number of orthopedic surgical procedures performed worldwide due to rising incidence of accidents and sports related injuries. Increasing prevalence of geriatric population around the world is another key factor contributing to the market growth. According to the 2015 World Aging Population report by the United Nations (UN), between 2015 and 2030, the global population aged 60 years and over is expected to grow by 56% from 901 million to 1.4 billion. This number is projected to further rise up to 2.1 billion by 2050. As geriatric people are more susceptible to orthopedic and spinal disorders, such high prevalence will largely contribute to the growth of orthobiologics market during the forecast period. However, factors such as high cost of the procedures and stringent regulatory approval processes can hinder the growth of orthobiologics market during the forecast period.

Get sample report here: https://www.crystalmarketresearch.com/report-sample/HC06151 .

Key Players:
Some of the key players operating in the orthobiologics market are, Bone Biologics Corporation, Bioventus LLC., RTI Surgical, Inc., Smith & Nephew PLC, Musculoskeletal Transplant Foundation, Seikagaku Corporation, AlloSource, Stryker Corporation, DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc.), Medtronic plc, Osiris Therapeutics, Inc., Kuros Biosciences AG, Globus Medical Inc., Wright Medical Group N.V, Arthrex, Inc., ISTO Technologies, Inc., CollPlant Ltd, OsteoMed and NuVasive, Inc.

The key opportunity for the players operating in orthobiologics market lies in the development of advanced reconstruction and repair products. Moreover, expanding distribution capabilities to explore and capture new marketplaces will facilitate a competitive edge for the major players in coming years. Increasing demand for patient specific therapy and rising incidence of spine related disorders will offer lucrative growth opportunities for the orthobiologics market in emerging countries during the next few years.

Spinal fusion segment accounted for the major share of the overall market in 2016 as the therapy delivers high bone stability along with rapid healing of the bones thus facilitating quick recovery for long-term spinal disorders. In spinal fusion, the rapid stimulation of cells initiates effective bone formation. Moreover, the therapy results in reduced duration of hospital stay which is a key contributing factor to the growth of this market.

Market Segmentation:

Orthobiologics Market By Product, Estimates and Forecast, 2016-2025 ($Million)
• Demineralized Bone Matrix (DBM)
• Viscosupplementation
• Bone Morphogenetic Protein (BMP)
• Allograft
• Stem Cell Therapy
• Synthetic Bone Substitutes

Orthobiologics Market By Application, Estimates and Forecast, 2016-2025 ($Million)
• Trauma Repair
• Spinal Fusion
• Reconstructive Surgery

Orthobiologics Market By End User, Estimates and Forecast, 2016-2025 ($Million)
• Orthopedic Clinics
• Hospitals

North America dominated the orthobiologics market in 2016 due to the abundant presence of prominent players in orthobiologics market in the region along with favorable reimbursement policies for fusion enhancement products and soft tissue healing. The Asia-Pacific orthobiologics market is expected to grow at the fastest rate over the forecast period owing to increasing healthcare expenditure in emerging countries along with rising disposable income of the people.

The major players in the orthobiologics market focus on new product development strategy to secure a competitive advantage over others. Moreover, they are involved in strategic collaborations, mergers and acquisitions to enhance their presence across different regional markets. For instance, in March 2016, Zimmer Biomet Holdings, Inc. secured an exclusive global distribution agreement with CelgenTek Innovations Corporation for its N-Force Fixation System and CelgenTek's iN3 cement. The agreement enabled CelgenTek to enhance its reach benefiting from Zimmer Biomet’s commercial capabilities.

Check Discount Now: https://www.crystalmarketresearch.com/check-discount/HC06151 .

Table of Content:
Part1. Introduction
1.1. Report Description
1.2. Research Methodology
…
Part2. Executive Summary
2.1. Key Highlights
…
Part3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
…
Part4. Orthobiologics Market, By Product
4.1. Introduction
4.2. Orthobiologics Market Assessment and Forecast, By Product, 2016-2025
4.3. Demineralized Bone Matrix
4.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4. Viscosupplementation
4.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.5. Bone Morphogenetic Protein
4.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
…
Part5. Orthobiologics Market, By Application
5.1. Introduction
5.2. Orthobiologics Market Assessment and Forecast, By Application, 2016-2025
5.3. Trauma Repair
5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.4. Spinal Fusion
5.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.5. Reconstructive Surgery
5.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
…
Part6. Orthobiologics Market, By End User
6.1. Introduction
6.2. Orthobiologics Market Assessment and Forecast, By End User, 2016-2025
6.3. Orthopedic Clinics
6.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
6.4. Hospitals
6.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
…
Part7. Orthobiologics Market, By Region
7.1. Introduction
7.2. Orthobiologics Market Assessment and Forecast, By Region, 2016-2025 ($Million)
7.3. North America
7.3.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)
7.3.2. Market Assessment and Forecast, By Product, 2016-2025 ($Million)
7.3.3. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
7.3.4. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
7.3.4.1. U.S.
7.3.4.1.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)
7.3.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
7.3.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
7.3.4.2. Canada
7.3.4.2.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)
7.3.4.2.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
7.3.4.2.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
7.3.4.3. Mexico
7.3.4.3.1. Market Assessment and Forecast, By Product, 2016-2025 ($Million)
7.3.4.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
7.3.4.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
7.4. Europe
Continue…

Click To buy Report now @ https://www.crystalmarketresearch.com/checkout/HC06151

About Crystal Market Research:
Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy S
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.